Rising Pharma Holding, Inc. recalls Rising
- Recalling company
- Rising Pharma Holding, Inc.
- Product
- Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
- Reason
- Presence of Precipitate: medication was crystallizing and particles floating in the bottle
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jul 13, 2026
- Reported
- Jul 29, 2026
- Distribution
- Nationwide U.S.A.
- Status
- Ongoing
- Quantity
- 74208 units
- Lot / codes
- Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.
- Company location
- East Brunswick, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0724-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0724-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.